IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 192 filers reported holding IMMUNITYBIO INC in Q2 2024. The put-call ratio across all filers is 2.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17 | +13.3% | 2,620 | -4.0% | 0.00% | – |
| Q1 2024 | $15 | +7.1% | 2,730 | 0.0% | 0.00% | – |
| Q4 2023 | $14 | +366.7% | 2,730 | +69.6% | 0.00% | – |
| Q3 2023 | $3 | -25.0% | 1,610 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | +33.3% | 1,610 | 0.0% | 0.00% | – |
| Q1 2023 | $3 | -62.5% | 1,610 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 1,610 | +8.6% | 0.00% | – |
| Q3 2022 | $7,000 | -92.6% | 1,483 | -94.2% | 0.00% | -100.0% |
| Q2 2022 | $95,000 | -24.6% | 25,589 | +14.1% | 0.00% | 0.0% |
| Q1 2022 | $126,000 | +31.2% | 22,432 | +42.4% | 0.00% | 0.0% |
| Q4 2021 | $96,000 | +68.4% | 15,756 | +170.7% | 0.00% | – |
| Q3 2021 | $57,000 | +418.2% | 5,820 | +680.2% | 0.00% | – |
| Q2 2021 | $11,000 | +120.0% | 746 | +245.4% | 0.00% | – |
| Q1 2021 | $5,000 | – | 216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 335,709 | $2,121,681 | 1.13% |
| Accurate Wealth Management, LLC | 560,000 | $3,561,600 | 0.85% |
| ALLEN HOLDING INC /NY | 687,571 | $4,345,449 | 0.54% |
| SHEETS SMITH WEALTH MANAGEMENT | 665,995 | $4,209,088 | 0.50% |
| Cormorant Asset Management, LP | 1,250,000 | $7,900,000 | 0.46% |
| Clearwater Capital Advisors, LLC | 482,549 | $3,049,710 | 0.32% |
| WEALTH EFFECTS LLC | 87,500 | $553,000 | 0.20% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $609,457 | 0.19% |
| Virtus ETF Advisers LLC | 56,107 | $354,596 | 0.17% |
| COLLECTIVE FAMILY OFFICE LLC | 70,355 | $444,644 | 0.13% |